Get the tools used by (smart)2 investors.

Unadjusted EBITDA CAGR (5y) for CVS Health Corp

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

CVS: CVS Health Corp

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits se...

67.05 USD
Price
USD
Fair Value
Upside
43.56 - 80.75
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on CVS Health Corp's Unadjusted EBITDA CAGR (5y):

CVSHLTH.USAHCOOMISSYAGLACCD-20.0%0.0%20.0%40.0%

Performance Summary
  • CVS Health's unadjusted ebitda cagr (5y) is -5.6%

Benchmarks

Metric Usage: Unadjusted EBITDA CAGR (5y)

Hide this widget
ebitda_unadj_cagr_5y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Unadjusted EBITDA CAGR (5y) in the growth category include:

View Full List

Search for metric or datapoint

Unadjusted EBITDA CAGR (5y)

Five-year compound annual growth rate in unadjusted EBITDA.

Definition of Unadjusted EBITDA CAGR (5y)

Hide this widget

Unadjusted EBITDA CAGR (5y) measures the five-year compound annual growth rate in Unadjusted EBITDA.

Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.

You can find the calculation details for CVS Health’s Unadjusted EBITDA CAGR outlined below. The calculation starts by listing values for Unadjusted EBITDA for the last six fiscal years that are required to calculate CAGR:

CVS Health's Unadjusted EBITDA History
Fiscal YearUnadjusted EBITDAYoY Growth
2019-12-31T00:00:00.000Z15.399 B
2020-12-31T00:00:00.000Z16.332 B6.1%
2021-12-31T00:00:00.000Z16.331 B0.0%
2022-12-31T00:00:00.000Z11.513 B−29.5%
2023-12-31T00:00:00.000Z17.05 B48.1%
2024-12-31T00:00:00.000Z11.555 B−32.2%

Using the values for Unadjusted EBITDA listed in the table above, we can calculate three-year Unadjusted EBITDA CAGR as follows:

 Number of years  =  5
 Multiplier       =  $11.555 B / $15.399 B  =  0.75
 5 Year CAGR     =  0.75 ^ (1/5) - 1  =  −5.6%

Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. CVS Health’s reports in the USD currency. You can read more about Unadjusted EBITDA here and compound annual growth rate on Wikipedia. You may also find variants three-year Unadjusted EBITDA CAGR, and seven-year Unadjusted EBITDA CAGR useful.


Click the link below to download a spreadsheet with an example Unadjusted EBITDA CAGR (5y) calculation for CVS Health Corp below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-31.6%-6.6%18.4%58.7%0204060

The chart above depicts the distribution of unadjusted ebitda cagr (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 420 companies were considered in this analysis, and 410 had meaningful values. The average unadjusted ebitda cagr (5y) of companies in the sector is 6.5% with a standard deviation of 15.0%.

CVS Health Corp's Unadjusted EBITDA CAGR (5y) of -5.6% ranks in the 18.6% percentile for the sector. The following table provides additional summary stats:

Unadjusted EBITDA CAGR (5y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents428
Included Constituents410
Min-33.5%
Max57.1%
Median6.1%
Mean6.5%
Standard Deviation15.0%

You can find companies with similar unadjusted ebitda cagr (5y) using this stock screener.

All rights reserved. Terms Of Use